Overview:

Summary

Clinical trial report, “Cerebral Infarction Global Clinical Trials Review, Q1, 2011"" provides data on the Cerebral Infarction clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Cerebral Infarction. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Cerebral Infarction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cerebral Infarction 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by BRIC Nations 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Unaccomplished Trials of Cerebral Infarction 18
Subjects Recruited Over a Period of Time 19
Prominent Sponsors 20
Top Companies Participating in Cerebral Infarction Therapeutics Clinical Trials 22
Prominent Drug Comparison 24
Clinical Trial Profiles 25
Clinical Trial Overview of Top Companies 25
Mitsubishi Tanabe Pharma Corporation 25
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 25
Otsuka Pharmaceutical Co., Ltd. 26
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 26
Ferrer Internacional S.A. 27
Clinical Trial Overview of Ferrer Internacional S.A. 27
Moleac Pte. Ltd. 28
Clinical Trial Overview of Moleac Pte. Ltd. 28
Merck & Co., Inc. 29
Clinical Trial Overview of Merck & Co., Inc. 29
GlaxoSmithKline plc 30
Clinical Trial Overview of GlaxoSmithKline plc 30
Sanofi-Aventis 31
Clinical Trial Overview of Sanofi-Aventis 31
Clinical Trial Overview of Top Universities / Institutes / Hospitals 32
Soroka University Medical Center 32
Clinical Trial Overview of Soroka University Medical Center 32
Severance Hospital 33
Clinical Trial Overview of Severance Hospital 33
Tianjin University of Traditional Chinese Medicine 34
Clinical Trial Overview of Tianjin University of Traditional Chinese Medicine 34
Nagoya University 35
Clinical Trial Overview of Nagoya University 35
University of Heidelberg 36
Clinical Trial Overview of University of Heidelberg 36
Asan Medical Center 37
Clinical Trial Overview of Asan Medical Center 37
University of Southern California 38
Clinical Trial Overview of University of Southern California 38
Bispebjerg Hospital 39
Clinical Trial Overview of Bispebjerg Hospital 39
University of Wuerzburg 40
Clinical Trial Overview of University of Wuerzburg 40
University of Medicine and Dentistry New Jersey 41
Clinical Trial Overview of University of Medicine and Dentistry New Jersey 41
Appendix 42
Abbreviations 42
Definitions 42
Research Methodology 43
Secondary Research 43
About GlobalData 44
Contact Us 44
Disclaimer 45
Source 45

List of Tables
Cerebral Infarction Therapeutics Market, Global, Clinical Trials by Zone, 2011* 7
Cerebral Infarction Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Cerebral Infarction Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2011* 9
Cerebral Infarction Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2011* 10
Cerebral Infarction Therapeutics Clinical Trials, Europe, Top Countries, 2011* 11
Cerebral Infarction Therapeutics Clinical Trials, North America, Top Countries, 2011* 12
Cerebral Infarction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 13
Cerebral Infarction Therapeutics Clinical Trials, BRIC Countries, 2011* 14
Cerebral Infarction Therapeutics Market, Global, Clinical Trials by Phase, 2011* 15
Cerebral Infarction Therapeutics Market, Global, Clinical Trials in Progress by Phase 2011* 16
Cerebral Infarction Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 17
Cerebral Infarction Therapeutics Market, Global, Terminated Clinical Trials, 2011* 18
Cerebral Infarction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Cerebral Infarction Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 21
Cerebral Infarction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 23
Cerebral Infarction Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 24
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2011* 25
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2011* 26
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferrer Internacional S.A., 2011* 27
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by Moleac Pte. Ltd., 2011* 28
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011* 29
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011* 30
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 2011* 31
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by Soroka University Medical Center, 2011* 32
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by Severance Hospital, 2011* 33
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by Tianjin University of Traditional Chinese Medicine, 2011* 34
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya University, 2011* 35
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2011* 36
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2011* 37
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern California, 2011* 38
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by Bispebjerg Hospital, 2011* 39
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wuerzburg, 2011* 40
Cerebral Infarction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2011* 41

List of Figures
Cerebral Infarction Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 7
Cerebral Infarction Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Cerebral Infarction Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2011* 9
Cerebral Infarction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 10
Cerebral Infarction Therapeutics Clinical Trials, Europe, Top Countries (%), 2011* 11
Cerebral Infarction Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 15
Cerebral Infarction Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2011* 16
Cerebral Infarction Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 17
Cerebral Infarction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Cerebral Infarction Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 20
Cerebral Infarction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 22
Cerebral Infarction Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 24
GlobalData Methodology 43